ahlam1399
08-28-2015, 11:55 PM
UPDATE 1-Baxalta in talks to buy hematology-oncology specialist -Bloomberg
Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bloomberg reported, citing people familiar with the...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=58CALsjtllQ:AcSyu0C3Quk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=58CALsjtllQ:AcSyu0C3Quk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/58CALsjtllQ
Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bloomberg reported, citing people familiar with the...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=58CALsjtllQ:AcSyu0C3Quk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=58CALsjtllQ:AcSyu0C3Quk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=58CALsjtllQ:AcSyu0C3Quk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/58CALsjtllQ